Download full-text PDF |
Source |
---|
Am J Transl Res
December 2024
Department of Gynecology, Suzhou Ninth People's Hospital Suzhou 215200, Jiangsu, China.
Objective: To investigate the factors influencing recurrence following laparoscopic conservative surgery in patients with ovarian endometriosis (OEM) and to develop a predictive model.
Methods: In this retrospective study, the clinical data from 212 OEM patients who underwent laparoscopic conservative surgery at Suzhou Ninth People's Hospital from May 2013 to December 2021 were meticulously reviewed. According to disease recurrence over a 2-year follow-up period, the patients were divided into a recurrence group and a non-recurrence group.
Expert Rev Med Devices
January 2025
Boston Scientific Neuromodulation, Valencia, California, USA.
Background: Fast-acting Sub-perception Therapy (FAST) is a novel spinal cord stimulation (SCS) modality delivering paresthesia-free pain relief. Our study evaluated the longer-term, real-world impact of FAST on chronic pain.
Research Design And Methods: As part of a multicenter, real-world, consecutive case series, we retrospectively identified patients who used FAST-SCS and analyzed their data.
Int J Surg Case Rep
January 2025
Janaki Medical College and Teaching Hospital, Janakpur, Nepal.
Introduction: Patellar sleeve fracture is a rare fracture common in children between the age of 8 and 16 years but rare in adults. We report a case of 22 year old male with inferior patellar sleeve fracture following motorbike accident.
Case Presentation: The case study presents a twenty-two year old boy who sustained inferior patellar Sleeve fractures following motor bike accident.
J Am Heart Assoc
January 2025
Pfizer Inc New York NY USA.
Background: The coexistence of transthyretin cardiac amyloidosis (ATTR-CA) and aortic stenosis (AS) is increasingly recognized, but the clinical consequences are unclear. We aimed to characterize clinical outcomes in AS plus ATTR-CA compared with only AS or ATTR-CA.
Methods And Results: In a retrospective cohort study, patients with AS only, ATTR-CA only, or AS plus ATTR-CA were identified using all-payer claims data (2015-2021).
J Arrhythm
February 2025
Global Specialty Medical Affairs Daiichi Sankyo, Inc. New York City NewYork USA.
Background: The non-vitamin K oral anticoagulant (NOAC), edoxaban, is approved for stroke prevention in patients with atrial fibrillation (AF) in many Asian countries. Nonetheless, data on its long-term effectiveness and safety in routine clinical practice are limited in Taiwan.
Methods: The Global ETNA-AF (Edoxaban Treatment in routiNe clinical prActice) registry is an observational study that integrates data of AF patients receiving edoxaban from multiple regional registries.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!